Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Delayed Quote • USD Clene Inc. (CLNNW) Follow Compare 0.0317 -0.0020 (-5.93%) At close: March 19 at 4:00:00 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for CLNNW 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: CLNNW View More All News Press Releases SEC Filings Clene to Present at the Jones Healthcare and Technology Innovation Conference Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025 Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights Bullish Clene Insiders Loaded Up On US$583.4k Of Stock Q1 Virtual Investor Summit: On-Demand Presentations Now Live Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment Clene to Present at the 37TH Annual Roth Conference Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11 Clene and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®’s Impact on NfL Reduction Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS